Therefore, the strong reduction in the incidence of dementia and PD and the inhibitory effects of the proliferation of human breast cancer cells could be explained by the potential novel biological pathway of inhibition to ERβ by simvastatin in Figure 7. This evidence concerns the gene ESR2 and breast carcinoma.